Answers are grounded in this paper and cite their sources.
Molecular microbiome analyses require high-resolution, comparable measurements, often obtained by sequencing marker genes such as the rRNA gene. Recently, new platforms and chemistries have promised to improve performance at lower cost relative to the commonly used Illumina MiSeq 2x300, but have not yet been systematically compared especially for rRNA gene amplicon studies. Here, we compared MiSeq 2x300, MiSeq 2x500, and AVITI 2x300 by sequencing mock communities and field samples via a 'universal' (16S + 18S) rRNA gene amplicons (V4-V5 region) approach. All platforms recovered similar community patterns (Mantel r > 0.93), with no major differences in recovered lineages. MiSeq 2x500 showed ~4.5-fold higher index hopping (5.9 +/- 3.8% vs. 1.3 +/- 1.5%). For 18S, MiSeq 2x500, despite longer reads overlapping the 18S V4-V5 region, only marginally improved taxonomic classification (+0.7% on average) and ASV resolution (+/-1.3%). Meanwhile, all platforms similarly biased against 18S due to its greater length, which we demonstrate can be offset by a gel-based size selection, with no apparent taxonomic bias. Overall the platforms yield ecologically similar results. We highlight platform-specific advantages to help guide decision-making and challenges that can be addressed through dedicated bioinformatic or wet-lab approaches.
No takes yet. Share an insight, caveat, or question.
D'Agostino et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: